The Global Cancer Immunotherapy Market size was valued at around USD 134.4 billion in 2024 and is projected to reach USD 214.7 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.12% during the forecast period, i.e., 2025-30. According to MarkNtel Advisors Study.

Global Cancer Immunotherapy Market Driver:

Increasing Frequency of Approvals Received by Novel Immunotherapies – Increasing acceptance of novel immunotherapies is expected to bode well for market expansion in the coming years. For instance, The U.S. FDA authorized a number of anti-PD-1/L1 antibodies between 2020 and 2022 for the treatment of NSCLC, renal cell carcinoma, melanoma, breast, prostate, and other malignancies. These antibodies include nivolumab, atezolizumab, avelumab, dostarlimab, and others. Therefore, the increased approval of immunotherapeutic drugs has fueled market development in the past few years.

Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/global-cancer-immunotherapy-market.html

Key Market Reports Highlights

• Market Dimensions & Projections
• Pricing Evaluation
• Recent Strategic Moves by Companies
• Primary Stakeholders
• Import/Export Trend Analysis
• Competitive Landscape Assessment
• Emerging Opportunities
• Market Trends and Indicators

*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Browse Full Report including(TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/global-cancer-immunotherapy-market.html

Global Cancer Immunotherapy Market Segmentation:

The market report categorizes the market based on different segments and geographical analysis.

Study Timeline:

-Base Year: 2024

-Historical Period: 2020 to 2023

-Forecast Period: 2025 to 2030

• By Product Type
  • Monoclonal Antibodies
  • Immunomodulators
  • Oncolytic Viral Therapies and Cancer Vaccines
  • Checkpoint Inhibitors
  • Others
• By Cancer Type
  • Lung Cancer
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Head and Neck Cancer
  • Melanoma
  • Colorectal Cancer
• By Mechanism of Actions
  • Active Immunotherapy
  • Passive Immunotherapy
• By End Users
  • Hospitals
  • Cancer Research Centers
  • Clinics
• By Region
  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia-Pacific  

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Amgen Inc., Astrazeneca, Bayer AG, Bristol-Myers Squibb, ELI Lilly and Company, Janssen Global Services LLC, Johnson and Johnson, Merck, Novartis, Pfizer, F., Hoffmann-La Roche Ltd. are looking forward to strengthening their market positions.

Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/global-cancer-immunotherapy-market.html

Global Cancer Immunotherapy Industry Recent Development:

In 2024: AstraZeneca decided to pay USD 18 million to Immunai (biotechnology firm) to use New York-based firm’s AI model of the immune system for cancer drug trials.

Data-Driven Insights Backed by Proven Research

We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.

From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.

About Us –

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Us

MarkNtel Advisors

Email: sales@marknteladvisors.com

Website: www.marknteladvisors.com

Latest Press Release – https://www.marknteladvisors.com/press-release